MYGN: Pangali PEG Myriad Genetics, Inc.

Logo korporat perusahaan myriad.com (MYGN)

Myriad Genetics, Inc. (MYGN) is shaping the molecular analysis landscape by integrating genetic tests into medical protocols. The PEG ratio reflects the business valuation dynamics, with the indicator currently standing at 0.00. This correlates with profit growth following IT system upgrades and the utilization of robust R&D resources to develop AI-driven early-stage cancer diagnostics.

MYGN (Myriad Genetics) riwayat Pangali PEG saka 04.07.2022 nganti 12.11.2026

Myriad Genetics, Inc. (MYGN) - rincian metrik lan laporan keuangan

- rega saham lan konsensus proyeksi valuasi:
Bagan owah-owahan rega Myriad Genetics Inc|MYGN - Prakiraan konsensus analis
- informasi kapitalisasi pasar:
Kapitalisasi pasar Myriad Genetics Corp|MYGN - Nilai Total Perusahaan
- data ekuitas miturut neraca:
Ekuitas saben Saham Myriad Genetics|MYGN - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku myriad.com|MYGN - Aset Agregat Perusahaan
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Myriad Genetics, Inc.|MYGN - Rasio utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal myriad.com|MYGN - Utang perusahaan|Utang-utang marang aset resik Myriad Genetics Corp|MYGN - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Myriad Genetics|Koefisien jangkoan perantara myriad.com
- indikator pendapatan resik lan kelipatan nilai:
MYGN - Bathi resik perusahaan|Bathi mangsa ngarep Myriad Genetics, Inc.|MYGN - Koefisien rega marang bathi|Rasio prakiraan rega marang bathi Myriad|MYGN - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Myriad Genetics Corp|MYGN - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Myriad Genetics|MYGN - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan myriad.com|MYGN - Wutah bathi ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Myriad Genetics, Inc.
Analisis fundamental perusahaan:MYGN, Myriad Genetics Inc
Sampel barang Myriad Genetics Corp

The PEG ratio compares the P/E multiple with earnings growth rates, where a value below one signals a fundamental undervaluation of the asset relative to its expansion. In the case of Myriad Genetics, Inc. (MYGN), the robotization of sequencing and the implementation of AI should accelerate profit scaling, making the PEG growth stock indicator a key tool for assessing the efficiency of the business's technological transition.

Perusahaan pesaing

CAI (Caris Life Sciences Inc) - Koefisien bali modal nimbang wutah|Pangali PEG GH (Guardant360)|Pangali PEG Veracyte Diagnostics VCYT|CELC - Rasio rega marang bathi tumrap wutah|GRAL (grail.com) - Rasio P/E diaturake wutah|CSTL: Pangali PEG|Burning Rock Biotech Limited (BNR) - Pangali PEG|Rasio rega marang bathi tumrap wutah VolitionRx Ltd.|Rasio rega marang bathi tumrap wutah BDSX|Pangali rega marang bathi tumrap wutah PRPO (Precipio, Inc.)|CHEK - Rega marang bathi kanthi panyesuaian wutah|Rasio rega marang bathi tumrap wutah Mainz Biomed N.V. MYNZ|Kapitalisasi marang bathi resik kanthi nimbang wutah OncoCyte Corp (OCX)